BrainCool AB (publ) (BRAIN.ST) Research

BrainCool AB (publ), a medical technology company founded in 2010 and headquartered in Lund, Sweden, focuses on the development, commercialization, and distribution of advanced medical cooling systems. Operating with its subsidiaries, the company caters to the healthcare sector, primarily serving the Swedish market, by providing innovative solutions for various conditions including stroke, sudden cardiac arrest, oral mucositis, and migraine. Their product line features the BrainCool and RhinoChill systems, specifically engineered to deliver swift therapeutic cooling in emergency situations, thereby ensuring uninterrupted patient care. To mitigate the risk of oral mucositis, BrainCool offers the Cooral system, renowned for its user-friendly design for medical professionals. Furthermore, the IQool system boasts an intuitive interface complemented by informative graphics and an automatic feedback loop, empowering clinicians to dedicate their attention to patient management rather than device operation.

Market snapshot

Symbol
BRAIN.ST
Price
$0.72
Day change
+2.14%
Market cap
$214.1M
P/E ratio
-5.20x
52-week range
0.4105-1.68
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • AcuCort AB (ACUC.ST)
  • Alzinova AB (publ) (ALZ.ST)
  • Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
  • Integrum AB (publ) (INTEG-B.ST)
  • Klaria Pharma Holding AB (publ.) (KLAR.ST)
  • Luxbright AB (publ) (LXB.ST)
  • Neola Medical AB (publ) (NEOLA.ST)
  • Nosa Plugs AB (NOSA.ST)

Open BrainCool AB (publ) (BRAIN.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.